Bayer AG

Bayer AG operates as a global life science company at the intersection of health, nutrition, and agriculture. Its Pharmaceuticals business researches, develops, manufactures, and markets products for disease prevention, diagnosis, and treatment, including therapies for serious and difficult to treat conditions. Consumer Health supplies nonprescription self care products for everyday health and well being. Through Crop Science, the company develops seeds, crop protection products, and agricultural innovations that support food production while considering the health of farmland.

With more than 160 years of innovation, Bayer serves customers in 79 countries and employed more than 63,000 people worldwide at the end of 2025. Research and development spans healthcare, crop solutions, digital technologies, artificial intelligence, and strategic partnerships, backed by €4.07 billion in research and development investment during 2025 and a workforce of more than 10,500 research and development employees. The group recorded sales of €45.6 billion and EBITDA of €9.7 billion for fiscal year 2025, operating under a dual governance structure comprising a Board of Management and Supervisory Board.